These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 9987832)

  • 1. Application of Schiff base copper(II) and iron(III) chelates to site-specific cleavage of a trypsin.
    Toyota E; Miyazaki H; Itoh K; Sekizaki H; Tanizawa K
    Chem Pharm Bull (Tokyo); 1999 Jan; 47(1):116-9. PubMed ID: 9987832
    [TBL] [Abstract][Full Text] [Related]  

  • 2. X-ray crystallographic analyses of complexes between bovine beta-trypsin and Schiff base copper(II) or iron(III) chelates.
    Toyota E; Ng KK; Sekizaki H; Itoh K; Tanizawa K; James MN
    J Mol Biol; 2001 Jan; 305(3):471-9. PubMed ID: 11152605
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis and evaluation of guanidine-containing Schiff base copper(II), zinc(II), and iron(III) chelates as trypsin inhibitors.
    Toyota E; Sekizaki H; Itoh K; Tanizawa K
    Chem Pharm Bull (Tokyo); 2003 Jun; 51(6):625-9. PubMed ID: 12808236
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Amidino-containing Schiff base copper(II) and iron(III) chelates as a thrombin inhibitor.
    Toyota E; Sekizaki H; Takahashi YU; Itoh K; Tanizawa K
    Chem Pharm Bull (Tokyo); 2005 Jan; 53(1):22-6. PubMed ID: 15635223
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Inhibition mechanism of trypsin by Schiff base metal chelate inhibitors].
    Iyaguchi D
    Yakugaku Zasshi; 2011; 131(9):1299-303. PubMed ID: 21881302
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structural basis for the design of novel Schiff base metal chelate inhibitors of trypsin.
    Iyaguchi D; Kawano S; Takada K; Toyota E
    Bioorg Med Chem; 2010 Mar; 18(6):2076-2080. PubMed ID: 20202854
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cytotoxic analogs of the iron(III) chelator pyridoxal isonicotinoyl hydrazone: effects of complexation with copper(II), gallium(III), and iron (III) on their antiproliferative activities.
    Richardson DR
    Antimicrob Agents Chemother; 1997 Sep; 41(9):2061-3. PubMed ID: 9303419
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dihydrolipoic acid lowers the redox activity of transition metal ions but does not remove them from the active site of enzymes.
    Suh JH; Zhu BZ; deSzoeke E; Frei B; Hagen TM
    Redox Rep; 2004; 9(1):57-61. PubMed ID: 15035828
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ascorbate autoxidation in the presence of iron and copper chelates.
    Buettner GR
    Free Radic Res Commun; 1986; 1(6):349-53. PubMed ID: 2851502
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biological activity of some Schiff bases and their metal complexes.
    Parashar RK; Sharma RC; Mohan G
    Biol Trace Elem Res; 1989-1990 Winter; 23():145-50. PubMed ID: 2484421
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis, DNA binding, and cleaving properties of an ellipticine-salen.copper conjugate.
    Routier S; Bernier JL; Catteau JP; Colson P; Houssier C; Rivalle C; Bisagni E; Bailly C
    Bioconjug Chem; 1997; 8(6):789-92. PubMed ID: 9404650
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Iron(III) complexes of a pyridoxal Schiff base for enhanced cellular uptake with selectivity and remarkable photocytotoxicity.
    Basu U; Pant I; Hussain A; Kondaiah P; Chakravarty AR
    Inorg Chem; 2015 Apr; 54(8):3748-58. PubMed ID: 25849848
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis, structural and biological studies of nickel(II), copper(II) and zinc(II) chelates with tridentate Schiff bases having NNO and NNS donor systems.
    Chohan ZH; Kausar S
    Chem Pharm Bull (Tokyo); 1993 May; 41(5):951-3. PubMed ID: 8339341
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Some new nano-sized Fe(II), Cd(II) and Zn(II) Schiff base complexes as precursor for metal oxides: Sonochemical synthesis, characterization, DNA interaction, in vitro antimicrobial and anticancer activities.
    Abdel-Rahman LH; Abu-Dief AM; El-Khatib RM; Abdel-Fatah SM
    Bioorg Chem; 2016 Dec; 69():140-152. PubMed ID: 27816797
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metal based pharmacologically active agents: synthesis, structural characterization, molecular modeling, CT-DNA binding studies and in vitro antimicrobial screening of iron(II) bromosalicylidene amino acid chelates.
    Abdel-Rahman LH; El-Khatib RM; Nassr LA; Abu-Dief AM; Ismael M; Seleem AA
    Spectrochim Acta A Mol Biomol Spectrosc; 2014 Jan; 117():366-78. PubMed ID: 24001978
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oxidative stress induced by a di-Schiff base copper complex is both mediated and modulated by glutathione.
    Steinkühler C; Pedersen JZ; Weser U; Rotilio G
    Biochem Pharmacol; 1991 Oct; 42(9):1821-7. PubMed ID: 1657001
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immobilized chymotrypsin by means of Schiff base copper(II) chelate.
    Moriya K; Tanizawa K; Kanaoka Y
    Biochem Biophys Res Commun; 1989 Jul; 162(1):408-14. PubMed ID: 2751659
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Copper complexes based on chiral Schiff-base ligands: DNA/BSA binding ability, DNA cleavage activity, cytotoxicity and mechanism of apoptosis.
    Zhou XQ; Li Y; Zhang DY; Nie Y; Li ZJ; Gu W; Liu X; Tian JL; Yan SP
    Eur J Med Chem; 2016 May; 114():244-56. PubMed ID: 26994692
    [TBL] [Abstract][Full Text] [Related]  

  • 19. DNA nuclease activity of Rev-coupled transition metal chelates.
    Joyner JC; Keuper KD; Cowan JA
    Dalton Trans; 2012 Jun; 41(21):6567-78. PubMed ID: 22450234
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A newly synthesized nickel chelate can selectively target and overcome multidrug resistance in cancer through redox imbalance both in vivo and in vitro.
    Banerjee K; Biswas MK; Choudhuri SK
    J Biol Inorg Chem; 2017 Dec; 22(8):1223-1249. PubMed ID: 29063196
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.